Guides

Everything we've written — peptide deep-dives, head-to-head comparisons, and research topics — organized in one place.

Peptide Guides

In-depth profiles of each peptide — mechanism, clinical data, dosing, and side effects.

Mechanism, clinical trial data, dosing protocols, and side effect profile for the most widely prescribed GLP-1 agonist.

How the dual GIP/GLP-1 agonist compares to semaglutide, what the SURMOUNT trials showed, and who it may benefit most.

The next-generation triple agonist targeting GIP, GLP-1, and glucagon receptors — Phase 2 data and what to expect.

Head-to-head analyses to help you understand the differences that matter.

Side-by-side look at efficacy, tolerability, cost, and availability based on head-to-head and cross-trial data.

Research findings, pricing news, and analysis from the PeptidePub blog.